Pre-seed · Raised $3.2M · Jul 17, 2026announcement ↗
Sightera Biosciences
BiotechBelgiumsightera-biosciences.com ↗
What they do
Sightera Biosciences is a Belgium-based biotech using generative AI, patient-derived tissue data, and robotic drug screening to design small-molecule therapies. Its pipeline targets oncology, fibrosis, and antibody-drug conjugate payloads, with programs focused on treatment-resistant cancers and biomarker-guided patient selection.
Hiring outlook
A $3.2 million pre-seed round suggests the company may next prioritize founding or early hires in computational drug discovery, machine learning, medicinal chemistry, translational biology, and laboratory automation. It may also add scientific or business-development leadership to support partnerships, but broad commercial hiring is less likely at this stage.
Open roles
Pre-flood window open
Nothing posted yet since the raise, which is exactly when a direct, well-aimed email to a founder beats every job portal. When the postings go up, so does the competition.
Get founders like this to reach you →